Entities / Company
Dynavax Technologies (United States).
company in Berkeley, United States
- Reports this week
- 0
- Active events
- 0
- Connections
- 44
What's happening
Gone quiet
No new reports in 90+ days-
Dynavax Technologies announced the UK approval of HEPLISAV-B and confirmed participation in the Wells Fargo Healthcare Conference.Some support2 reports
-
Dynavax Technologies, a company in the biomedical and genetics industry, underperformed the market index on August 8, 2025.Some support1 report
-
GSK and Dynavax Technologies reported that their drug candidate Z-1018 shows promise against Shingrix.Some support2 reports
-
Dynavax seeks supplemental FDA filing for adults.Some support1 report
No events began in the chosen period. Widen it, or reset.
Connections
The 2 strongest of 44, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Institutional Shareholder Services Mentioned together
ISS provides reports and recommendations regarding Dynavax's board elections and director nominees.
-
Scott Myers Structural
Scott Myers is nominated to serve as a director for Dynavax Technologies.
History
Events by the month they beganJune 2026
4 events- Dynavax Technologies announced the UK approval of HEPLISAV-B and confirmed participation in the Wells Fargo Healthcare Conference.
- Dynavax Technologies, a company in the biomedical and genetics industry, underperformed the market index on August 8, 2025.
- GSK and Dynavax Technologies reported that their drug candidate Z-1018 shows promise against Shingrix.
- Dynavax seeks supplemental FDA filing for adults.